AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Cash From Financing

Annual CFF:

-$49.09M-$43.96M(-856.96%)
December 31, 2024

Summary

  • As of today, AUPH annual cash from financing is -$49.09 million, with the most recent change of -$43.96 million (-856.96%) on December 31, 2024.
  • During the last 3 years, AUPH annual cash from financing has fallen by -$270.20 million (-122.20%).
  • AUPH annual cash from financing is now -120.13% below its all-time high of $243.85 million, reached on December 31, 2019.

Performance

AUPH Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Quarterly CFF:

-$10.36M+$35.74M(+77.52%)
September 30, 2025

Summary

  • As of today, AUPH quarterly cash from financing is -$10.36 million, with the most recent change of +$35.74 million (+77.52%) on September 30, 2025.
  • Over the past year, AUPH quarterly cash from financing has dropped by -$7.58 million (-272.09%).
  • AUPH quarterly cash from financing is now -105.07% below its all-time high of $204.59 million, reached on December 31, 2021.

Performance

AUPH Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CFF:

-$127.95M-$7.58M(-6.30%)
September 30, 2025

Summary

  • As of today, AUPH TTM cash from financing is -$127.95 million, with the most recent change of -$7.58 million (-6.30%) on September 30, 2025.
  • Over the past year, AUPH TTM cash from financing has dropped by -$96.48 million (-306.50%).
  • AUPH TTM cash from financing is now -132.52% below its all-time high of $393.45 million, reached on September 30, 2020.

Performance

AUPH TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

AUPH Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-857.0%-272.1%-306.5%
3Y3 Years-122.2%-10000.0%-162.0%
5Y5 Years-120.1%-105.4%-132.5%

AUPH Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-122.2%at low-732.4%+79.0%-162.0%at low
5Y5-Year-120.1%at low-105.1%+79.0%-132.5%at low
All-TimeAll-Time-120.1%at low-105.1%+79.0%-132.5%at low

AUPH Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$10.36M(+77.5%)
-$127.95M(-6.3%)
Jun 2025
-
-$46.11M(+6.6%)
-$120.38M(-46.1%)
Mar 2025
-
-$49.34M(-122.8%)
-$82.38M(-71.3%)
Dec 2024
-$49.09M(-857.0%)
-$22.15M(-695.1%)
-$48.09M(-52.8%)
Sep 2024
-
-$2.79M(+65.6%)
-$31.48M(-1.4%)
Jun 2024
-
-$8.11M(+46.1%)
-$31.03M(-42.5%)
Mar 2024
-
-$15.05M(-172.0%)
-$21.77M(-328.3%)
Dec 2023
-$5.13M(-310.9%)
-$5.53M(-136.4%)
-$5.08M(-576.0%)
Sep 2023
-
-$2.34M(-303.5%)
$1.07M(-68.4%)
Jun 2023
-
$1.15M(-29.8%)
$3.38M(-5.1%)
Mar 2023
-
$1.64M(+164.8%)
$3.57M(+52.9%)
Dec 2022
$2.43M(-98.9%)
$619.00K(+2690.0%)
$2.33M(-98.9%)
Sep 2022
-
-$23.90K(-101.8%)
$206.30M(-4.2%)
Jun 2022
-
$1.33M(+229.1%)
$215.24M(-0.0%)
Mar 2022
-
$405.00K(-99.8%)
$215.28M(-2.1%)
Dec 2021
$221.11M(+13.8%)
$204.59M(+2194.7%)
$219.91M(+1018.5%)
Sep 2021
-
$8.92M(+547.5%)
$19.66M(-90.3%)
Jun 2021
-
$1.38M(-72.6%)
$202.67M(+0.2%)
Mar 2021
-
$5.03M(+15.9%)
$202.19M(+1.1%)
Dec 2020
$194.38M(-20.3%)
$4.34M(-97.7%)
$200.08M(-49.1%)
Sep 2020
-
$191.92M(>+9900.0%)
$393.45M(+81.5%)
Jun 2020
-
$897.50K(-69.3%)
$216.83M(+0.3%)
Mar 2020
-
$2.92M(-98.5%)
$216.27M(-11.7%)
Dec 2019
$243.85M(+5975.1%)
$197.71M(+1191.6%)
$245.00M(+411.7%)
Sep 2019
-
$15.31M(+4492.7%)
$47.88M(+47.0%)
Jun 2019
-
$333.30K(-98.9%)
$32.56M(-8.5%)
Mar 2019
-
$31.65M(+5264.6%)
$35.59M(+803.4%)
Dec 2018
$4.01M(-97.7%)
$590.00K(+5828.2%)
$3.94M(+164.6%)
Sep 2018
-
-$10.30K(-100.3%)
$1.49M(-87.4%)
Jun 2018
-
$3.36M(>+9900.0%)
$11.84M(+78.0%)
Mar 2018
-
$0.00(+100.0%)
$6.65M(-96.3%)
Dec 2017
$175.15M(+311.0%)
-$1.86M(-118.0%)
$178.83M(-14.3%)
Sep 2017
-
$10.34M(+665.8%)
$208.69M(+1.4%)
Jun 2017
-
-$1.83M(-101.1%)
$205.81M(-4.0%)
Mar 2017
-
$172.18M(+515.0%)
$214.49M(+406.9%)
Dec 2016
$42.62M(+4979.3%)
$28.00M(+275.2%)
$42.31M(+195.5%)
Sep 2016
-
$7.46M(+8.9%)
$14.32M(+108.4%)
Jun 2016
-
$6.85M(>+9900.0%)
$6.87M(+1480.1%)
Mar 2016
-
$0.00(-100.0%)
$434.90K(-45.9%)
Dec 2015
$839.00K(-98.2%)
$2700.00(-81.5%)
$803.90K(+1664.0%)
Sep 2015
-
$14.60K(-96.5%)
-$51.40K(-109.8%)
Jun 2015
-
$417.60K(+13.2%)
$522.10K(+277.0%)
Mar 2015
-
$369.00K(+143.3%)
$138.50K(-99.7%)
Dec 2014
$46.69M(+666.7%)
-$852.60K(-245.0%)
$45.41M(-1.3%)
Sep 2014
-
$588.10K(+1629.7%)
$45.99M(-9.8%)
Jun 2014
-
$34.00K(-99.9%)
$50.97M(-1.5%)
Mar 2014
-
$45.64M(>+9900.0%)
$51.74M(+749.6%)
Dec 2013
$6.09M(+753.9%)
-$271.00K(-104.9%)
$6.09M(-14.4%)
Sep 2013
-
$5.56M(+591.2%)
$7.11M(+362.5%)
Jun 2013
-
$805.00K(>+9900.0%)
$1.54M(+112.9%)
Mar 2013
-
-$8000.00(-101.1%)
$722.30K(+0.4%)
Dec 2012
$713.20K
$752.50K(+6700.9%)
$719.30K(+597.4%)
Sep 2012
-
-$11.40K(-5.6%)
-$144.60K(+11.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$10.80K(+1.8%)
-$163.30K(-48.3%)
Mar 2012
-
-$11.00K(+90.1%)
-$110.10K(-104.8%)
Dec 2011
$2.35M(-47.8%)
-$111.40K(-270.1%)
$2.28M(-6.4%)
Sep 2011
-
-$30.10K(-171.0%)
$2.43M(-65.2%)
Jun 2011
-
$42.40K(-98.2%)
$6.99M(+0.4%)
Mar 2011
-
$2.38M(+5349.8%)
$6.96M(+51.8%)
Dec 2010
$4.51M(+151.1%)
$43.60K(-99.0%)
$4.59M(+9.9%)
Sep 2010
-
$4.53M(>+9900.0%)
$4.17M(+560.4%)
Jun 2010
-
$16.50K(>+9900.0%)
-$906.20K(-602.9%)
Mar 2010
-
$0.00(+100.0%)
$180.20K(+101.9%)
Dec 2009
-$8.82M(-175.0%)
-$371.20K(+32.7%)
-$9.54M(+12.2%)
Sep 2009
-
-$551.50K(-150.0%)
-$10.86M(-0.2%)
Jun 2009
-
$1.10M(+111.3%)
-$10.84M(-1197.8%)
Mar 2009
-
-$9.72M(-473.3%)
$987.70K(-90.5%)
Dec 2008
$11.77M(-64.6%)
-$1.69M(-217.9%)
$10.37M(-25.5%)
Sep 2008
-
-$533.10K(-104.1%)
$13.92M(-11.1%)
Jun 2008
-
$12.93M(+3978.0%)
$15.66M(+249.0%)
Mar 2008
-
-$333.50K(-118.0%)
$4.49M(-87.7%)
Dec 2007
$33.24M(+2642.2%)
$1.85M(+53.2%)
$36.38M(+6.5%)
Sep 2007
-
$1.21M(-31.5%)
$34.16M(+5.0%)
Jun 2007
-
$1.76M(-94.4%)
$32.54M(+7.0%)
Mar 2007
-
$31.56M(+8676.1%)
$30.41M(+2435.9%)
Dec 2006
-$1.31M(-108.9%)
-$368.00K(+10.6%)
-$1.30M(-190.2%)
Sep 2006
-
-$411.50K(-11.5%)
-$448.60K(-103.0%)
Jun 2006
-
-$369.20K(-141.0%)
$14.93M(-2.3%)
Mar 2006
-
-$153.20K(-131.6%)
$15.29M(+1.3%)
Dec 2005
$14.63M(+225.4%)
$485.30K(-96.8%)
$15.10M(-3.1%)
Sep 2005
-
$14.97M(>+9900.0%)
$15.58M(+248.0%)
Jun 2005
-
-$11.90K(+96.5%)
$4.48M(+0.6%)
Mar 2005
-
-$343.20K(-135.5%)
$4.45M(-7.1%)
Dec 2004
$4.49M(-80.3%)
$965.80K(-75.0%)
$4.79M(+8.5%)
Sep 2004
-
$3.87M(>+9900.0%)
$4.42M(-69.2%)
Jun 2004
-
-$38.20K(-2446.7%)
$14.36M(-41.5%)
Mar 2004
-
-$1500.00(-100.3%)
$24.53M(+1.1%)
Dec 2003
$22.80M(+83.7%)
$591.50K(-95.7%)
$24.26M(+2.7%)
Sep 2003
-
$13.81M(+36.3%)
$23.61M(+143.2%)
Jun 2003
-
$10.13M(+3822.4%)
$9.71M(+9.3%)
Mar 2003
-
-$272.10K(-421.3%)
$8.88M(-28.4%)
Dec 2002
$12.41M(-60.3%)
-$52.20K(+44.3%)
$12.41M(-43.1%)
Sep 2002
-
-$93.70K(-101.0%)
$21.81M(-46.4%)
Jun 2002
-
$9.30M(+185.5%)
$40.72M(+22.7%)
Mar 2002
-
$3.26M(-65.1%)
$33.18M(+8.3%)
Dec 2001
$31.26M(+90.3%)
-
-
Dec 2001
-
$9.35M(-50.3%)
$30.62M(+43.9%)
Sep 2001
-
$18.81M(+966.7%)
$21.28M(+763.2%)
Jun 2001
-
$1.76M(+151.4%)
$2.47M(+251.4%)
Mar 2001
-
$701.50K(-77.1%)
$701.50K(-83.3%)
Dec 2000
$16.43M(+296.0%)
-
-
Nov 1999
$4.15M(+159.4%)
$3.07M(+681.9%)
$4.20M(+271.3%)
Aug 1999
-
-$527.20K(-231.7%)
$1.13M(-31.8%)
May 1999
-
$400.40K(-68.2%)
$1.66M(+31.8%)
Feb 1999
-
$1.26M
$1.26M
Nov 1998
$1.60M
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual cash from financing year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from financing year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from financing year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual cash from financing?

The current annual cash from financing of AUPH is -$49.09M

What is the all-time high annual cash from financing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual cash from financing is $243.85M

What is Aurinia Pharmaceuticals Inc. annual cash from financing year-on-year change?

Over the past year, AUPH annual cash from financing has changed by -$43.96M (-856.96%)

What is Aurinia Pharmaceuticals Inc. quarterly cash from financing?

The current quarterly cash from financing of AUPH is -$10.36M

What is the all-time high quarterly cash from financing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly cash from financing is $204.59M

What is Aurinia Pharmaceuticals Inc. quarterly cash from financing year-on-year change?

Over the past year, AUPH quarterly cash from financing has changed by -$7.58M (-272.09%)

What is Aurinia Pharmaceuticals Inc. TTM cash from financing?

The current TTM cash from financing of AUPH is -$127.95M

What is the all-time high TTM cash from financing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM cash from financing is $393.45M

What is Aurinia Pharmaceuticals Inc. TTM cash from financing year-on-year change?

Over the past year, AUPH TTM cash from financing has changed by -$96.48M (-306.50%)
On this page